MAC ANAESTHESIA LIMITED

Active Wilmslow

Specialists medical practice activities

1 employees website.com
Specialists medical practice activities
M

MAC ANAESTHESIA LIMITED

Specialists medical practice activities

Founded 8 Apr 2022 Active Wilmslow, England 1 employees website.com
Specialists medical practice activities
Accounts Submitted 4 Jul 2025 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 8 Apr 2026 Next due 21 Apr 2027 10 months remaining
Net assets £151K £68K 2025 year on year
Total assets £175K £72K 2025 year on year
Total Liabilities £24K £5K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Sandison Easson & Co Rex Buildings Alderley Road Wilmslow Cheshire SK9 1HY England

Full company profile for MAC ANAESTHESIA LIMITED (14036649), an active company based in Wilmslow, England. Incorporated 8 Apr 2022. Specialists medical practice activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type micro-entity
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

N/A

Net Assets

£150.81k

Increased by £67.62k (+81%)

Total Liabilities

£23.98k

Increased by £4.78k (+25%)

Turnover

N/A

Employees

1

Debt Ratio

14%

Decreased by 5 (-26%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Clayton, Matthew Andrew, DrDirectorBritishEngland468 Apr 2022Active

Shareholders

Shareholders (1)

Matthew Andrew Clayton
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Matthew Andrew Clayton

British

Active
Notified 8 Apr 2022
Residence United Kingdom
DOB November 1979
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Dr Matthew Andrew Clayton

British

Active
Notified 8 Apr 2022
Residence United Kingdom
DOB November 1979
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026Confirmation StatementConfirmation statement made on 7 Apr 2026 with no updates
4 Jul 2025AccountsAnnual accounts made up to 30 Apr 2025
8 Apr 2025Persons With Significant ControlChange to Dr Matthew Andrew Clayton as a person with significant control on 8 Apr 2025
8 Apr 2025OfficersChange to director Dr Matthew Andrew Clayton on 8 Apr 2025
8 Apr 2025OfficersChange to director Dr Matthew Andrew Clayton on 8 Apr 2025
8 Apr 2026 Confirmation Statement

Confirmation statement made on 7 Apr 2026 with no updates

4 Jul 2025 Accounts

Annual accounts made up to 30 Apr 2025

8 Apr 2025 Persons With Significant Control

Change to Dr Matthew Andrew Clayton as a person with significant control on 8 Apr 2025

8 Apr 2025 Officers

Change to director Dr Matthew Andrew Clayton on 8 Apr 2025

8 Apr 2025 Officers

Change to director Dr Matthew Andrew Clayton on 8 Apr 2025

Recent Activity

Latest Activity

Confirmation statement made on 7 Apr 2026 with no updates

2 months ago on 8 Apr 2026

Annual accounts made up to 30 Apr 2025

11 months ago on 4 Jul 2025

Change to Dr Matthew Andrew Clayton as a person with significant control on 8 Apr 2025

1 years ago on 8 Apr 2025

Change to director Dr Matthew Andrew Clayton on 8 Apr 2025

1 years ago on 8 Apr 2025

Change to director Dr Matthew Andrew Clayton on 8 Apr 2025

1 years ago on 8 Apr 2025